Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Intellectual Property Watch

Intellectual Property Law

: Intellectual Property Watch

Obama 2012 Budget Proposal Reduces Exclusivity For Biologics

By Intellectual Property Watch

Shortly after passage last year of the US healthcare reform act called for a regulatory pathway to bring follow-on biologic drugs, or biosimilars, to market with 12 years of data exclusivity for brand-name producers, the Obama administration has proposed to reduce that time to its original 7 years, according to sources. The move, contained in the 2012 budget proposal, is expected to allow lower priced generic versions of drugs to enter the market sooner, a benefit to consumers.

Related Articles:

• US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics
• Would Canada-EU Trade Proposals Add $2.8 Billion Price Tag To Drugs Bill?
• Pharma Industry To Publish Clinical Trial Results

Full post as published by Intellectual Property Watch on February 15, 2011 (boomark / email).